Back

Consistent effect on Kansas City cardiomyopathy questionnaire overall summary score with acoramidis treatment compared with placebo across all subgroups in ATTRibute-CM

9 May 2026 (12:56 - 13:50)
Organised by: Logo
Congress Presentation Part of: ePosters in myocardial disease (2) Clinical Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Professor Marianna Fontana

University College London, London (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Weak grip, slow rise - associations with cardiac enzymes and NYHA functional class: handgrip strength and chair rise test performance as potential prognostic markers in cardiac ATTR and AL amyloidosis
Ms C. Dolderer (Wuerzburg, DE)
Abstract Slides
Presentation thumbnail
Advanced echocardiographic phenotyping reveals distinct functional patterns in cardiomyopathies with increased LV mass
Doctor F. Sahiti (Wurzburg, DE)
Abstract Slides
Presentation thumbnail
The heart after transplant: long-term cardiovascular outcomes in hereditary ATTRv Amyloidosis
Doctor J. AGOSTINHO (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Cardiac amyloidosis in older patients: can we predict hereditary vs wild-type subtype?
Doctor B. Andrade (Santarem, PT)
Abstract Slides
Presentation thumbnail
Takotsubo syndrome in real-world practice: a tertiary centre case series
Doctor J. Fernandes Pedro (Lisbon, PT)
Abstract Slides

Access the full session

Session thumbnail
ePosters in myocardial disease (2)

The Event

Event poster

Heart Failure 2026

9 May 2026 12:56 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources